| Literature DB >> 35011102 |
Elena Paillaud1,2,3, Johanne Poisson1,3, Clemence Granier3,4, Antonin Ginguay5,6, Anne Plonquet7, Catherine Conti1,2, Amaury Broussier2,8, Agathe Raynaud-Simon3,9, Sylvie Bastuji-Garin2,10.
Abstract
We aimed to determine whether serum leptin levels are predictive of the occurrence of healthcare-associated infections (HAIs) in hospitalized older patients. In a prospective cohort, 232 patients had available data for leptin and were monitored for HAIs for 3 months. Admission data included comorbidities, invasive procedures, the Mini Nutritional Assessment (MNA), BMI, leptin, albumin and C-reactive protein levels, and CD4 and CD8 T-cell counts. Multivariate logistic regression modelling was used to identify predictors of HAIs. Of the 232 patients (median age: 84.8; females: 72.4%), 89 (38.4%) experienced HAIs. The leptin level was associated with the BMI (p < 0.0001) and MNA (p < 0.0001) categories. Women who experienced HAIs had significantly lower leptin levels than those who did not (5.9 μg/L (2.6-17.7) and 11.8 (4.6-26.3), respectively; p = 0.01; odds ratio (OR) (95% confidence interval): 0.67 (0.49-0.90)); no such association was observed for men. In a multivariate analysis of the women, a lower leptin level was significantly associated with HAIs (OR = 0.70 (0.49-0.97)), independently of comorbidities, invasive medical procedures, and immune status. However, leptin was not significantly associated with HAIs after adjustments for malnutrition (p = 0.26) or albuminemia (p = 0.15)-suggesting that in older women, the association between serum leptin levels and subsequent HAIs is mediated by nutritional status.Entities:
Keywords: hospital-acquired infection; leptin; malnutrition; older women
Mesh:
Substances:
Year: 2022 PMID: 35011102 PMCID: PMC8747117 DOI: 10.3390/nu14010226
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Sociodemographic, nutritional, and laboratory characteristics of 232 patients hospitalized in a geriatric rehabilitation unit.
| MD | Total Population | Women | Men | |
|---|---|---|---|---|
| Baseline characteristics | ||||
| Age (years) | 84.8 [81.2–90.1] | 84.5 [81–90] | 84 [79–87] | |
| ADL score | 8 [4–12] | 8 [5–12] | 8 [3.5–11] | |
| CIRS-G score | 11 [9–14] | 11 [9–14] | 13 [10–15] | |
| Invasive procedures | 70 (30.2) | 27 (42.2) | 43 (25.6) | |
| MMSE score | 6 | 21 [16–25] | 21 [16–25] | 21 [17–26] |
| Body mass index (kg/m2) | ||||
| <22 | 78 (33.6) | 62 (36.9) | 16 (25) | |
| 22–29.9 | 112 (48.3) | 74 (44.05) | 38 (59.4) | |
| ≥30 | 42 (18.1) | 32 (19.05) | 10 (15.6) | |
| MNA | ||||
| Malnutrition, <17 | 50 (21.6) | 38 (22.6) | 12 (18.8) | |
| At risk, 17–23.5 | 125 (53.9) | 90 (53.6) | 35 (54.7) | |
| Normal, 24–30 | 57 (24.6) | 40 (23.8) | 17 (26.6) | |
| Serum albumin (g/L) | 1 | 33.9 [30.9–37.4] | 34 [30.9–37.3] | 33.7 [30.8–37.5] |
| Serum C-reactive protein (mg/L) | 1 | 6 [2.5–17] | 5 [2.5–13] | 8.5 [2.5–31] |
| Serum leptin (μg/L) | 9.3 [3.7–21.6] | 10.5 [4–24.4] | 7.3 [2.5–12.6] | |
| Immunological factors | ||||
| CD4/CD8 T-cell ratio | 7 | 2.5 [1.4–3.5] | 2.4 [1.4–3.5] | 2.7 [1.4–3.5] |
|
| 7 | |||
| Naïve CD45RA+CD62L+ (%) | 17.5 [13.3–22.9] | 17.1 [12.9–22.1] | 18.8 [15–24.5] | |
|
| ||||
| Naïve CD45RA+CD62L+ (%) | 7 | 5 [3.3–7.3] | 5.1 [3.5–7.1] | 4.7 [3–7.8] |
| Peripheral memory CD45RA−CD62L− (%) | 7 | 2.7 [1.5–5] | 2.6 [1.4–5.4] | 2.9 [1.8–4.5] |
| Terminal effector CD28− (%) | 8 | 56 [38.5–69] | 56 [37–69] | 55 [42–66] |
| 3-month outcome | ||||
| Discharge to home | 127 (55.7) | 36 (57.1) | 91 (55.2) | |
| Discharge to an institution | 57 (25.0) | 14 (22.2) | 43 (26.1) | |
| Still in hospital | - | 30 (13.2) | 7 (11.1) | 23 (13.9) |
| Deceased | - | 14 (6.1) | 6 (9.5) | 8 (4.9) |
MD—missing data; ADL—activities of daily living; CIRS-G—Cumulative Illness Rating Scale, Geriatric; MMSE—Mini-Mental State Examination; MNA—mini nutritional assessment. The data are quoted as the number (%) or the median [interquartile range].
Baseline characteristics and outcomes associated with the leptin level in the study population (n = 232).
| Leptin Level (μg/L) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Women (N = 168) | Men (N = 64) | Total Population (N = 232) | ||||||||
| 10.6 [4–24.4] | 7.3 [2.5–12.6] | 9.3 [3.7–21.6] | ||||||||
| Spearman’s rho | Spearman’s rho | Spearman’s rho | ||||||||
| Baseline characteristics | ||||||||||
| Age (years) | −0.15 | 0.048 | −0.09 | 0.50 | ||||||
| Serum albumin (g/L) | 0.20 | 0.01 | −0.02 | 0.89 | ||||||
| Serum C reactive protein (mg/L) | 0.10 | 0.20 | −0.15 | 0.25 | ||||||
| CD4/CD8 T-cell ratio | −0.102 | 0.20 | −0.015 | 0.91 | −0.9 | 0.16 | ||||
|
| ||||||||||
| Naïve (CD45RA+CD62L+) (%) | −0.019 | 0.81 | 0.27 | 0.034 | ||||||
|
| ||||||||||
| Naïve (CD45RA+CD62L+) (%) | 0.08 | 0.28 | −0.013 | 0.92 | 0.08 | 0.23 | ||||
| Peripheral memory (CD45RA−CD62L−) (%) | −0.028 | 0.72 | 0.04 | 0.78 | −0.008 | 0.91 | ||||
| Terminal effector CD28− (%) | 0.15 | 0.06 | −0.13 | 0.31 | 0.09 | 0.20 | ||||
| N | Median [IQR] |
| N | Median [IQR] |
| N | Median [IQR] |
| ||
| Body mass index | <22 | 62 | 3.5 [2.1–5.6] | <0.000 | 16 | 2.5 [1.1–4.8] | <0.000 | 3.3 [1.6–5.1] | <0.000 | |
| 22–29.9 | 74 | 13.9 [8.6–25.2] | 38 | 7.5 [2.8–11.9] | 11 [5.1–21] | |||||
| ≥30 | 32 | 45.9 [21.7–72.6] | 10 | 21.4 [12.9–48] | 38.1 [20.4–66] | |||||
| MNA | <17 | 38 | 3.8 [1.9–8.5] | <0.000 | 12 | 2.4 [0.95–6.3] | <0.000 | 50 | 3.5 [1.5–7.1] | <0.000 |
| 17–23.5 | 90 | 10.7 [4.2–25.2] | 35 | 5.7 [2.4–12.4] | 125 | 9.5 [4–22.1] | ||||
| 24–30 | 40 | 21.8 [10.3–47] | 17 | 12.4 [9.2–15] | 57 | 16.4 [9.3–33] | ||||
| Outcome | ||||||||||
| Healthcare-associated infection | No | 105 | 11.8 [4.6–26.3] | 0.01 | 38 | 6.4 [2.5–11.9] | 0.35 | |||
| Yes | 63 | 5.9 [2.6–17.7] | 26 | 7.9 [2.4–12.9] | ||||||
MNA—Mini Nutritional Assessment; median [IQR], median [interquartile range]. a p value from Spearman’s rank correlation test or the Kruskal−Wallis test, as appropriate, b p value for the quantile regression models, adjusted for sex.
Univariate analyses of women with vs. without one of more healthcare-associated infections (n = 168).
| HAI+ | HAI− | Univariate Analysis | ||
|---|---|---|---|---|
| N = 63 | N = 105 | OR [95%CI] b | ||
| Age (years) | 85.5 [82–89] | 85 [81–90] | 0.78 | - |
| ADL | 7 [3–10] | 9 [6–12] | 0.001 | 0.88 [0.82–0.95] |
| CIRS-Gc | 13 [10–16] | 10 [8–12] | <0.000 | 2.02 [1.39–2.94] |
| Invasive procedure | 39 (52.9) | 11 (9.7) | <0.000 | 10.43 [4.77–22.83] |
| Body mass index (kg/m2) | 0.29 | |||
| <22 | 28 (44.4) | 34 (32.4) | 1.61 [0.81–3.23] | |
| 22–29.9 | 25 (39.7) | 49 (46.7) | Ref. | |
| ≥30 | 10 (15.9) | 22 (21) | 0.90 [0.37–2.17] | |
| MNA | 0.001 | |||
| <17 | 24 (38.1) | 14 (13.3) | 5.90 [2.19–15.93] | |
| 17–23.5 | 30 (47.6) | 60 (57.1) | 1.72 [0.73–4.08] | |
| 24–30 | 9 (14.3) | 31 (29.5) | Ref | |
| Albumin d (g/L) | 31.6 [28.7–34.1] | 35.7 [31.9–37.8] | <0.000 | 0.39 [0.25–0.59] |
| C-reactive protein (mg/L) c | 8 [2.5–20] | 2.5 [2.4–11] | 0.01 | 1.65 [1.20–2.28] |
| CD4/CD8 ratio d | 2.0 [1.29–3.16] | 2.56 [1.55–3.77] | 0.07 | 0.75 [0.54–1.04] |
| Naïve CD4+ T-cells (CD45RA+CD62L+) (%) | 16.5 [12.7–23.1] | 17.25 [13.2–21.6] | 0.53 | - |
|
| ||||
| Naïve (CD45RA+CD62L+) (%) d | 4.8 [3.2–7] | 5.25 [3.95–7.55] | 0.05 | 0.69 [0.49–0.96] |
| Peripheral memory (CD45RA−CD62L−) (%) c | 2.9 [1.5–10.4] | 2.35 [1.1–4.65] | 0.03 | 1.53 [1.07–2.18] |
| Terminal effector CD28− (%) c | 62.5 [30–73] | 52 [37.5–66] | 0.09 | 1.09 [0.89–1.50] |
| Leptin level (μg/L) d | 5.9 [2.6–17.7] | 11.8 [4.6–26.3] | 0.01 | 0.67 [0.49–0.90] |
HAI—healthcare-associated infection; OR—odds ratio; CI—confidence interval; ADL—activities of daily living; CIRS-G—Cumulative Illness Rating Scale, Geriatric; MNA—mini nutritional assessment. The data are quoted as the number (%) or median [interquartile range]. a p value from a chi-squared test or the Kruskal−Wallis test, as appropriate; b odds ratios (95%CI) were estimated using logistic regression models; c The odds ratios (95%CI) estimated using logistic regression models are quoted for a 1-SD increment in the log transformed values or d a 1-SD decrease in the log transformed values.
Figure 1Adjustments for the ADL and CIRS-G scores; invasive procedures; serum CRP; serum albumin; the CD4/CD8 ratio; and the naïve CD8 T-cell, memory CD8 T-cell and effectors CD8 T-cell counts did not substantially change the relationship between the leptin level and the occurrence of HAIs.
Multivariate analyses of women with at least one healthcare-associated infection vs. women without infections (n = 168).
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| OR [95%CI] | OR [95%CI] | OR [95%CI] | ||||
| CIRS-G a | 1.58 [1.04–2.39] | 0.03 | 1.54 [1.01–2.34] | 0.044 | ||
| Invasive procedure | 6.30 [2.66–14.92] | <0.001 | 6.44 [2.73–15.20] | <0.001 | 6.23 [2.61–14.87] | <0.001 |
| Naïve CD8+ T-cells (CD45RA+CD62L+)% b | 0.68 [0.46–0.99] | 0.043 | 0.70 [0.49–1.03] | 0.07 | 0.64 [0.43–0.94] | 0.02 |
| Serum leptin level (μg/L) b | 0.70 [0.49–0.97] | 0.048 | ||||
| Albumin | 0.46 [0.29–0.74] | 0.001 | ||||
| MNA < 17 | 3.22 [1.36–7.63] | 0.008 | ||||
OR—odds ratio; CI—confidence interval; CIRS-G—Cumulative Illness Rating Scale, Geriatric; MNA—Mini Nutritional Assessment. The multivariate analysis was adjusted for all variables of the model. a The odds ratios (95%CI) estimated using logistic regression models are quoted for a 1-SD increment in the log transformed values or b a 1-SD decrease in the log transformed values.